Page last updated: 2024-09-03

tazobactam and ro13-9904

tazobactam has been researched along with ro13-9904 in 23 studies

Compound Research Comparison

Studies (tazobactam)	Trials (tazobactam)	Recent Studies (post-2010) (tazobactam)	Studies (ro13-9904)	Trials (ro13-9904)	Recent Studies (post-2010) (ro13-9904)
1,327	153	694	6,815	798	2,755

Research

Studies (23)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (30.43)	18.2507
2000's	7 (30.43)	29.6817
2010's	4 (17.39)	24.3611
2020's	5 (21.74)	2.80

Authors

Authors	Studies
Jones, R; Satishchandran, V; Shapiro, T; Suh, B; Truant, AL	1
Appelbaum, PC; Jacobs, MR; Pankuch, GA	1
Aldridge, KE; Morice, N; Schiro, DD	1
Hardegger, U; Wüst, J	1
Edelstein, MA; Edelstein, PH	1
Eliopoulos, GM; Moellering, RC; Pefanis, A; Thauvin-Eliopoulos, C	1
Buxbaum, A; Georgopoulos, A; Graninger, W	1
Amato, R; Andò, F; Azzaro, R; Bellissima, P; Cicciarella, S; Covelli, I; Delia, S; Fogliani, V; Fraschini, F; Girbino, G; Jacoviello, C; Laganà, P; Magrì, M; Maierna, G; Maria, GD; Marone, P; Messina, G; Muscianisi, G; Napoletano, G; Pela, R; Pezza, A; Rizza, S; Rossi, A; Sabato, V; Sanguinetti, C; Tedeschi, D; Varotto, F; Viola, B; Vitale, S	1
Fixson, A; Glasmacher, A; Gorschlüter, M; Hahn, C; Horré, R; Marklein, G; Mey, U; Molitor, E; Sauerbruch, T; Schmidt-Wolf, IG; Ziske, C	1
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL	1
Arora, V; Prakash, SK; Prashad, R; Sharma, VK	1
Carreras, E; Fernández-Avilés, F; Gallego, C; García, L; Gaya, A; González, M; Granell, M; Hernando, A; Martínez, C; Montserrat, E; Ramiro, L; Rovira, M; Segura, S; Urbano-Ispizua, A; Valverde, M	1
Khan, HM; Malik, A; Shahid, M; Shujatullah, F; Shukla, I; Singhai, M; Tahira, F	1
Chen, SW; Liu, XK; Wu, HY; Zhang, LL; Zhang, SC	1
Braun, L; Fairchok, M; Flanagan, R; Mahlen, S; Sainato, R	1
Bailoor, K; Chen, T	1
Gutiérrez-Gutiérrez, B; Kahlmeter, G; Rodríguez-Baño, J	1
Berdaï, D; Boyer, A; Prevel, R	1
Cisera, K; Hughes, C; Rogers, B; Taylor, L; Xie, O	1
Albanell-Fernández, M; Aranda, L; Bartra, J; Gelis, S; González-García, R; López-Cabezas, C; Soy Muner, D	1
Sun, J; Xie, L; Xu, R; Zhu, D	1
Arenere-Mendoza, M; Fernández-de-Gamarra-Martínez, E; Fernández-Polo, A; González-Suárez, S; Gutiérrez-Urbón, JM; Nicolás-Picó, J; Rodríguez-Mateos, ME; Sánchez-Yáñez, E	1
Bautista, J; Beique, L; Cayen, J; Choi, K; Comeau, JL; Conly, J; Dalton, B; Delport, J; Dhami, R; Embree, J; Émond, Y; Evans, G; Frenette, C; Fryters, S; Happe, J; Katz, K; Kibsey, P; Langley, JM; Lee, BE; Lefebvre, MA; Leis, JA; McGeer, A; McKenna, S; Neville, HL; Pelude, L; Rudnick, W; Science, M; Slayter, K; Suh, KN; Thirion, DJG; Tse-Chang, A; Weiss, K	1

Trials

3 trial(s) available for tazobactam and ro13-9904

Article	Year
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Gentamicins; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Treatment Outcome	2003
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:5 Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections	2003
Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Oct-20, Volume: 24, Issue:30 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; Busulfan; Ceftriaxone; Female; Fever; Health Care Costs; Hematologic Neoplasms; Home Care Services; Hospital Charges; Humans; Inpatients; Male; Middle Aged; Neutropenia; Patient Readmission; Penicillanic Acid; Piperacillin; Stem Cell Transplantation; Tazobactam; Transplantation, Autologous	2006

Other Studies

20 other study(ies) available for tazobactam and ro13-9904

Article	Year
In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species. Diagnostic microbiology and infectious disease, 1995, Volume: 21, Issue:2 Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefotaxime; Ceftazidime; Ceftriaxone; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Sulbactam; Tazobactam	1995
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:12 Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Clavulanic Acids; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Streptococcus pneumoniae; Sulbactam; Tazobactam; Ticarcillin	1994
Increased in vitro activity of ceftriaxone by addition of tazobactam against clinical isolates of anaerobes. Diagnostic microbiology and infectious disease, 1994, Volume: 19, Issue:4 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamase Inhibitors; Ceftriaxone; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam	1994
In vitro activity of ceftriaxone combined with tazobactam against anaerobic bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13, Issue:2 Topics: Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Ceftriaxone; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam	1994
In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:2 Topics: Animals; Ceftriaxone; Cells, Cultured; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Therapy, Combination; Extracellular Space; Guinea Pigs; Intracellular Fluid; Legionella; Legionella pneumophila; Legionnaires' Disease; Macrophages, Alveolar; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam	1994
Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilis. The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:2 Topics: Abdomen; Abscess; Animals; Bacteroides fragilis; Bacteroides Infections; Ceftriaxone; Disease Models, Animal; Drug Therapy, Combination; Male; Penicillanic Acid; Peritoneal Diseases; Rats; Rats, Sprague-Dawley; Tazobactam	1993
Efficacy of beta-lactam and inhibitor combinations in a diffusion chamber model in rabbits. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:4 Topics: Animals; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Diffusion Chambers, Culture; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Rabbits; Tazobactam	1999
An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone. Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Disease Susceptibility; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam	2001
In vitro activity of ceftriaxone plus tazobactam against members of Enterobacteriaceae. The Journal of the Association of Physicians of India, 2005, Volume: 53 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Inhibitors; Hospital Units; In Vitro Techniques; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam	2005
In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Ceftriaxone; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam	2007
[Post antibiotic, post beta-lactamase inhibitor and post antibiotic sub-MIC effect of ceftriaxone/tazobactam on beta-lactamase-producing Escherichia coli in vitro]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2009, Volume: 40, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Ceftriaxone; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam	2009
Severe human parechovirus sepsis beyond the neonatal period. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 51, Issue:1 Topics: Anti-Bacterial Agents; Blood Coagulation Disorders; Ceftriaxone; Enterocolitis, Necrotizing; Enzyme Inhibitors; Fever; Heart Failure; Hepatitis; Humans; Infant; Male; Parechovirus; Penicillanic Acid; Picornaviridae Infections; Piperacillin; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sepsis; Sequence Analysis, RNA; Tazobactam	2011
Fungating groin mass in a woman with a history of follicular lymphoma. BMJ case reports, 2017, Aug-16, Volume: 2017 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ceftriaxone; Cyclophosphamide; Diagnosis, Differential; Escherichia coli Infections; Female; Groin; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Penicillanic Acid; Piperacillin; Positron-Emission Tomography; Rituximab; Tazobactam; Tomography, X-Ray Computed; Vincristine	2017
Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections. JAMA, 2019, 02-12, Volume: 321, Issue:6 Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tazobactam	2019
Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections. JAMA, 2019, 02-12, Volume: 321, Issue:6 Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tazobactam	2019
Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection. Annals of clinical microbiology and antimicrobials, 2020, Nov-30, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tazobactam	2020
Evaluation of desensitization protocols to betalactam antibiotics. Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:5 Topics: Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Drug Hypersensitivity; Humans; Meropenem; Reproducibility of Results; Retrospective Studies; Review Literature as Topic; Tazobactam	2022
Emerging resistance to ceftriaxone treatment owing to different ampD mutations in Enterobacter roggenkampii. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2022, Volume: 102 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftriaxone; Drug Resistance, Bacterial; Enterobacter; Enterobacter cloacae; Humans; Liver Abscess; Microbial Sensitivity Tests; Mutation; Piperacillin; Tazobactam	2022
PAUSATE Study: Prevalence and appropriateness of the use of antimicrobials in Spanish hospitals. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2022, 08-02, Volume: 46, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Cross-Sectional Studies; Hospitals; Humans; Meropenem; Piperacillin; Prevalence; Tazobactam	2022
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018. Antimicrobial resistance and infection control, 2023, 04-18, Volume: 12, Issue:1 Topics: Adult; Anti-Infective Agents; Canada; Cefazolin; Ceftriaxone; Child; Cross Infection; Hospitals; Humans; Infant, Newborn; Inpatients; Piperacillin; Tazobactam	2023